Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-242-250"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110308.22.2-242-250"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Influenza A (H1N1), caused by the influenza A H1N1 virus, was initially detected in Mexico at the end of March 2009, and subsequently spread to various countries. In May 2009, the World Health Organisation (WHO) attributed moderate severity to influenza A (H1N1), and in June of the same year, the WHO declared a level 6 alert, corresponding to a pandemic phase. This maximum-level alert declared by the WHO set in train a series of measures in Europe. In some cases, these were very costly measures (for example, the costs were estimated at EUR 1.3 billion in Great Britain and EUR 990 million in France, compared to EUR 87 million against seasonal influenza). The response was disproportionate. Each Member State reacted in its own right, without much coherence or solidarity. This report, which I supported, reaches the correct conclusions in recommending greater coordination between Member States and European health institutions, as well as clarification and a review of the roles and responsibilities of the key players and management structures, and threats to health at a European level. Finally, it recognises the need for studies on vaccines and anti-viral medications that are independent of the pharmaceutical industry, including with regard to the monitoring of vaccination coverage."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples